Healthcare Industry - Medical - Pharmaceutical - Biotech in Seoul, Korea, South
18th World Stroke Congress (WSC 2026) | October 21 - 23, 2026 | Seoul, Korea
Gangnam District
Wednesday, October 21, 2026
0900
- 1800
Free
Healthcare Industry - Medical - Pharmaceutical - Biotech
Set against the dynamic backdrop of Seoul, WSC 2026, the 18th World Stroke Congress, will bring together leading stroke professionals, researchers, members of stroke support organizations, and policymakers to advance stroke care and research.
This year's congress ..
APLAR (Asia-Pacific League of Associations for Rheumatology) Congress 2026
Gangnam District
Wednesday, October 28, 2026
0800
- 1800
200.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
The congress will be held from 28 October 2026 (Wednesday) to 1 November 2026 (Sunday) at the COEX Convention and Exhibition Center in Seoul, South Korea, Republic of Korea. It will be a celebration of not just the fantastic hospitality and welcoming nature of our Ko ..
BioClina 2026 – International Conference on Biological & Clinical Studies, 18-19 June, Seoul
Seoul South Korea
Thursday, June 18, 2026
0900
- 1600
60.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Conference Name: BioClina 2026 – International Conference on Biological & Clinical Studies, 18-19 June, Seoul
Conference Dates: 18-19 June 2026
Conference Venue: Kwangwoon University, 20 Gwangun-ro, Nowon-gu, Seoul, South Korea
Contact E-Mail ID: convener@eu ..
5th World ADC Summit South Korea
Seoul
Tuesday, June 9, 2026
0800
- 1630
1649.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
The 5th World ADC Summit South Korea (9-11 June 2026 | Seoul) is Asia's premier meeting dedicated to accelerating next-generation antibody drug conjugate (ADC) development. As part of the broader World Targeted Therapeutics Summit South Korea, it sits alongside the W ..
World Bispecific and T-Cell Engager Summit South Korea
Gangseo-gu
Tuesday, June 9, 2026
0800
- 1630
1649.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Bispecifics and T-cell engagers are redefining the future of solid tumor treatment. With the landmark approvals of tarlatamab and ivonescimab, the spotlight is firmly on these modalities as powerful solutions for long-standing unmet needs. At the same time, the field ..
XXVII World Congress of Neurology (WCN 2025)
Seoul
Sunday, October 12, 2025
0900
- 2000
1.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Dear Friends, Dear Colleagues,
It is our great pleasure to invite you to the XXVII World Congress of Neurology (WCN 2025), to be held in Seoul, South Korea, from October 12-15, 2025. Co-hosted by the Korean Neurological Association, this congress promises to be a ..